JWM
XERS icon

JPL Wealth Management’s Xeris Biopharma Holdings XERS Stock Holding History

JPL Wealth Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35 Buy
+6
New +$40 ﹤0.01% 1519

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JPL Wealth Management's XERS Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 6 shares worth $35. The stake represents ﹤0.01% of the portfolio and ranks #1519 among its holdings.

237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • JPL Wealth Management held 6 shares of Xeris Biopharma Holdings worth $35 as of Q1 2026.
  • Xeris Biopharma Holdings was a new JPL Wealth Management position in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of JPL Wealth Management's portfolio in Q1 2026, its #1519 holding.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.